Authors
Loading...
Retrospective analysis shows high-dose methotrexate reduces disease progression in high-risk DLBCL patients, indicating potential for improved outcomes.
Honorato et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: